UConn R & D Companies

Advanced Trauma Solutions

Advanced Trauma Solutions is a behavioral health service company that provides training and consultation based on a therapeutic treatment protocol for psychological trauma. UConn R&D is working with Advanced Behavioral Health in Middletown, CT, as a strategic partner to develop this business utilizing the research of Dr. Julian Ford, Associate Professor and Director of the Center for Trauma Response, Recovery and Preparedness (CTRP) at the UConn Health Center. The Company will provide training using a detailed methodology developed by Dr. Ford.

New Ortho Polymers, Inc.
New Ortho Polymers, Inc. (NOP) is based on patented technology using polymer materials in orthodontic appliances developed by Drs. Charles Burstone and Jon Goldberg at UConn's School of Dental Medicine. NOP is applying self-reinforced polymer material to create the first polymer-based, esthetic arch wire for commercial use. NOP also utilizes a patented shape memory polymer technology developed by Dr. Pat Mather, formerly at UConn's Institute of Materials Science in Storrs, to create orthodontic appliances for tooth movement. The Company has been awarded an STTR grant from the National Institutes of Health and has recently secured seed capital financing. See Press Release.  

Renzulli Learning
Dr. Joe Renzulli and Dr. Sally Reis, of the School of Education’s Neag Center for Gifted Education & Talent Development at Storrs, have developed a series of tests and teaching materials to identify a student's primary learning style, abilities, interests, and preferred modes of expression. Using this student profile as a guide, the Company’s enrichment activity search engine instantly matches every student’s strength and interest to a vast variety of relevant learning activities and resources, including virtual fieldtrips, real fieldtrips, creativity training, summer programs, books, projects, independent studies, and much more. The Company has also released a home edition called the Renzulli ScoreBooster (see Print Release). Renzulli Learning reported sales of over $3 million in 2007, a 100% increase over FY2006. See additional News Article and web site.

Synaptic Dynamics, Inc.
Based on the research of Dr. Ben Bahr, Associate Professor of Pharmacology and Neurotoxicology, and Dr. Dennis Wright, Associate Professor of Medicinal Chemistry, the Company plans to develop drugs that promote the clearance of protein accumulations at neural synapses found in Alzheimer's Disease. The project has secured $65,000 in prototype funding and is in the process of establishing proof-of-concept.

Venomix
The Company is based on the work of Dr. Glenn King, formerly at UConn's Department of Molecular, Microbial and Structural Biology. Dr. King's research focuses on the use of spider venoms as a source of natural insect toxins. Venomix, using proprietary targets with little or no vertebrate toxicity, develops new insecticidal compounds using high-throughput screening and rational design methods. These products are targeted at the agricultural, specialty non-crop, and animal health markets, which have a combined market value (for insecticides only) of $15 billion. The Company has a cooperative research agreement with Chemtura Corporation, a $3 billion specialty chemical company. Recently, Venomix completed a Series A financing with SWMF Life Science Venture Fund, LP for $2.25 million. See additional Press Release and News Article.

Contact UConn R & D for more information on its companies.